{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:07:35Z","timestamp":1790712455393,"version":"4.1.0"},"reference-count":250,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Psoriasis (PSO) and atopic dermatitis (AD) are the two most common chronic inflammatory skin diseases in clinical practice. For a long time, they have been classified in pathological immunology under the opposing model of \u201cTh17\/IL-17 vs. Th2\/IL-4-IL-13.\u201d However, over the past decade, with the rise of immunometabolism, our understanding of chronic inflammatory diseases has undergone a significant shift. Metabolic pathways in immune cells are no longer viewed merely as auxiliary systems providing energy, but rather as core regulatory networks that determine cellular differentiation and effector functions. In psoriasis, hallmark features include upregulation of glycolysis, activation of hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1), abnormalities in cholesterol metabolism, and Warburg-like metabolism in keratinocytes. In AD, defects in epidermal ceramide synthesis, impaired essential fatty acid metabolism, disruption of the tryptophan-kynurenine pathway, and abnormal aromatics receptor (AhR) signaling constitute its unique metabolic profile. This article systematically reviews the distinct pathways of metabolic reprogramming in keratinocytes and immune cells in psoriasis and AD, and summarizes the mechanisms of action of key molecules such as mTOR and AMPK. Furthermore, it explores the differential therapeutic potential of metabolism-targeted drugs, including metformin, statins, PPAR\u03b3 agonists, and AhR modulators. Furthermore, the expression of common regulatory factors such as HIF-1\u03b1, PPAR\u03b3, and SREBP exhibits opposite trends in the two diseases. Finally, the article discusses the differential therapeutic potential of these metabolite-targeted drugs. This paper compares psoriasis and AD within a unified metabolic immunology framework, aiming to elucidate how these two diseases evolve from similar inflammatory responses into conditions with distinctly different clinical manifestations, and to provide a new theoretical foundation for future metabolism-based personalized therapies.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1879634","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:39:36Z","timestamp":1784180376000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Divergent immunometabolic reprogramming in psoriasis and atopic dermatitis: a tale of two inflammatory skin diseases"],"prefix":"10.3389","volume":"17","author":[{"given":"Nan","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Dermatology, Xuancheng People\u2019s Hospital","place":["Xuancheng, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehong","family":"Yue","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Shaoyang Central Hospital","place":["Shaoyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of General Medicine, the Second Affiliated Hospital of Wannan Medical College","place":["Wuhu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s0001-7310(09)73374-5","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"16082","DOI":"10.1177\/247553031319a00301","article-title":"Psoriasis","volume":"2","author":"Greb","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1159\/000131424","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.14.1735","article-title":"Risk of myocardial infarction in patients with psoriasis","volume":"296","author":"Gelfand","year":"2006","journal-title":"JAMA"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.08.015","article-title":"Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies","volume":"68","author":"Armstrong","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(11)60486-5","article-title":"Attributable risk estimate of severe psoriasis on major cardiovascular events","volume":"124","author":"Mehta","year":"2011","journal-title":"Am J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780198737582.003.0002","article-title":"Psoriasis and comorbid diseases: epidemiology","volume":"76","author":"Takeshita","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(15)00149-x","article-title":"Atopic dermatitis","volume":"4","author":"Weidinger","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)31286-1","article-title":"Atopic dermatitis","volume":"396","author":"Langan","year":"2020","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2017.02.002","article-title":"Public health burden and epidemiology of atopic dermatitis","volume":"35","author":"Silverberg","year":"2017","journal-title":"Dermatol Clin"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2010.22.2.125","article-title":"Atopic dermatitis","volume":"358","author":"Bieber","year":"2008","journal-title":"N Engl J Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.01.011","article-title":"The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies","volume":"139","author":"Brunner","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.06.010","article-title":"Cellular and molecular immunologic mechanisms in patients with atopic dermatitis","volume":"138","author":"Werfel","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaci.2018.10.032","article-title":"Atopic dermatitis endotypes and implications for targeted therapeutics","volume":"143","author":"Czarnowicki","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.coi.2017.08.008","article-title":"Atopic dermatitis and psoriasis: two different immune diseases or one spectrum","volume":"48","author":"Guttman-Yassky","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.12.1124","article-title":"Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities","volume":"127","author":"Su\u00e1rez-Fari\u00f1as","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"244ra90","DOI":"10.1126\/scitranslmed.3008946","article-title":"Intraindividual genome expression analysis reveals a specific molecular signature of psoriasis and eczema","volume":"6","author":"Quaranta","year":"2014","journal-title":"Sci Transl Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.07.012","article-title":"Progressive activation of T(H)2\/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis","volume":"130","author":"Gittler","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1314258","article-title":"Secukinumab in plaque psoriasis - results of two phase 3 trials","volume":"371","author":"Langley","year":"2014","journal-title":"N Engl J Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1512711","article-title":"Phase 3 trials of ixekizumab in moderate-to-severe plaque psoriasis","volume":"375","author":"Gordon","year":"2016","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.11.041","article-title":"Efficacy and safety of guselkumab compared with adalimumab for plaque psoriasis: results from VOYAGE 1","volume":"76","author":"Blauvelt","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.11.042","article-title":"Efficacy and safety of guselkumab compared with adalimumab for plaque psoriasis: results from VOYAGE 2","volume":"76","author":"Reich","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1610020","article-title":"Two phase 3 trials of dupilumab versus placebo in atopic dermatitis","volume":"375","author":"Simpson","year":"2016","journal-title":"N Engl J Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1314768","article-title":"Dupilumab treatment in adults with moderate-to-severe atopic dermatitis","volume":"371","author":"Beck","year":"2014","journal-title":"N Engl J Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.25251\/skin.4.supp.96","article-title":"Tralokinumab for moderate-to-severe atopic dermatitis: ECZTRA 1 and ECZTRA 2","volume":"184","author":"Wollenberg","year":"2021","journal-title":"Br J Dermatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(21)00588-2","article-title":"Once-daily upadacitinib versus placebo in atopic dermatitis (Measure Up 1 and Measure Up 2): two phase 3 trials","volume":"397","author":"Guttman-Yassky","year":"2021","journal-title":"Lancet"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2019380","article-title":"Abrocitinib versus placebo or dupilumab for atopic dermatitis","volume":"384","author":"Bieber","year":"2021","journal-title":"N Engl J Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2004.tb00672.x","article-title":"Unique keratinization process in psoriasis: late differentiation markers are abolished because of the premature cell death","volume":"31","author":"Iizuka","year":"2004","journal-title":"J Dermatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/nature05663","article-title":"Pathogenesis and therapy of psoriasis","volume":"445","author":"Lowes","year":"2007","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12470233","article-title":"Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin","volume":"96","author":"Imokawa","year":"1991","journal-title":"J Invest Dermatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.p030338","article-title":"Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients","volume":"53","author":"MacIver","year":"2012","journal-title":"J Lipid Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.98006","article-title":"Lipid abnormalities in atopic skin are driven by type 2 cytokines","volume":"3","author":"Pearce","year":"2018","journal-title":"JCI Insight"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.161","article-title":"Changes in the ceramide profile of atopic dermatitis patients","volume":"130","author":"Geltink","year":"2010","journal-title":"J Invest Dermatol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.01.022","article-title":"Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms","volume":"121","author":"Elias","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.133","article-title":"Epidermal barrier dysfunction in atopic dermatitis","volume":"129","author":"Olenchock","year":"2008","journal-title":"J Invest Dermatol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jdermsci.2013.02.001","article-title":"New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity","volume":"70","author":"Kabashima","year":"2013","journal-title":"J Dermatol Sci"},{"key":"B38","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jaci.2016.06.002","article-title":"Multifactorial skin barrier deficiency and atopic dermatitis: essential topics to prevent the atopic march","volume":"138","author":"Egawa","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/s1074-7613(02)00323-0","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O'Neill","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.04.004","article-title":"Metabolic instruction of immunity","volume":"169","author":"Buck","year":"2017","journal-title":"Cell"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.04.005","article-title":"Metabolic pathways in immune cell activation and quiescence","volume":"38","author":"Pearce","year":"2013","journal-title":"Immunity"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032712-095956","article-title":"Metabolic regulation of T lymphocytes","volume":"31","author":"MacIver","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1126\/science.1242454","article-title":"Fueling immunity: insights into metabolism and lymphocyte function","volume":"342","author":"Pearce","year":"2013","journal-title":"Science"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-042617-053019","article-title":"Unraveling the complex interplay between T cell metabolism and function","volume":"36","author":"Geltink","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1074\/jbc.r115.693903","article-title":"Immunometabolism: cellular metabolism turns immune regulator","volume":"291","author":"Loftus","year":"2016","journal-title":"J Biol Chem"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.04.013","article-title":"Biochemical underpinnings of immune cell metabolic phenotypes","volume":"46","author":"Olenchock","year":"2017","journal-title":"Immunity"},{"key":"B47","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41577-019-0203-y","article-title":"Metabolic coordination of T cell quiescence and activation","volume":"20","author":"Chapman","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0032-5","article-title":"Targeting metabolism to regulate immune responses in autoimmunity and cancer","volume":"18","author":"Patel","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/s1074-7613(02)00323-0","article-title":"The CD28 signaling pathway regulates glucose metabolism","volume":"16","author":"Michalek","year":"2002","journal-title":"Immunity"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.09.021","article-title":"The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation","volume":"35","author":"Gerriets","year":"2011","journal-title":"Immunity"},{"key":"B51","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cmet.2014.05.004","article-title":"The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function","volume":"20","author":"Sinclair","year":"2014","journal-title":"Cell Metab"},{"key":"B52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1600-065x.2012.01150.x","article-title":"Metabolic switching and fuel choice during T-cell differentiation and memory development","volume":"249","author":"van der Windt","year":"2012","journal-title":"Immunol Rev"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20151159","article-title":"T cell metabolism drives immunity","volume":"212","author":"Buck","year":"2015","journal-title":"J Exp Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1146\/annurev-immunol-020711-075024","article-title":"Regulation of immune responses by mTOR","volume":"30","author":"Powell","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/nri3198","article-title":"Regulation and function of mTOR signalling in T cell fate decisions","volume":"12","author":"Chi","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.09.008","article-title":"HIF transcription factors, inflammation, and immunity","volume":"41","author":"Palazon","year":"2014","journal-title":"Immunity"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-15-0507","article-title":"MYC, metabolism, and cancer","volume":"5","author":"Stine","year":"2015","journal-title":"Cancer Discov"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003613","article-title":"Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets","volume":"186","author":"Danso","year":"2011","journal-title":"J Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1172\/jci76012","article-title":"Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation","volume":"125","author":"van Smeden","year":"2015","journal-title":"J Clin Invest"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2556","article-title":"Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation","volume":"14","author":"Sinclair","year":"2013","journal-title":"Nat Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"6692","DOI":"10.1038\/ncomms7692","article-title":"PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation","volume":"6","author":"Veldhoen","year":"2015","journal-title":"Nat Commun"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02318","article-title":"The metabolic requirements of Th2 cell differentiation","volume":"10","author":"Stark","year":"2019","journal-title":"Front Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2001029","article-title":"Targeting in vivo metabolic vulnerabilities of Th2 and Th17 cells reduces airway inflammation","volume":"206","author":"Hu","year":"2021","journal-title":"J Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01632","article-title":"Metabolism controls the balance of Th17\/T-regulatory cells","volume":"8","author":"Sun","year":"2017","journal-title":"Front Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2016.10.009","article-title":"Metabolic pathways in T cell activation and lineage differentiation","volume":"28","author":"Almeida","year":"2016","journal-title":"Semin Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800013","article-title":"Discovery of the IL-23\/IL-17 signaling pathway and the treatment of psoriasis","volume":"201","author":"Hawkes","year":"2018","journal-title":"J Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/s40291-020-00507-1","article-title":"Epigenetics in non-tumor immune-mediated skin diseases","volume":"25","author":"Reolid","year":"2021","journal-title":"Mol Diagn Ther"},{"key":"B69","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jdermsci.2017.05.005","article-title":"Altered expression of epidermal lipid bio-synthesis enzymes in atopic dermatitis skin","volume":"88","author":"Karagianni","year":"2017","journal-title":"J Dermatol Sci"},{"key":"B70","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000441540","article-title":"Stratum corneum lipids: their role for the skin barrier function in healthy subjects and atopic dermatitis patients","volume":"49","author":"van Smeden","year":"2016","journal-title":"Curr Probl Dermatol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1186\/s12895-020-00102-1","article-title":"The ceramide [NP]\/[NS] ratio in the stratum corneum is a potential marker for skin properties and epidermal differentiation","volume":"20","author":"Iizuka","year":"2020","journal-title":"BMC Dermatol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/nature05663","article-title":"Multi-omics approach to improved diagnosis and treatment of atopic dermatitis and psoriasis","volume":"25","author":"Rusi\u00f1ol","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/nature06881","article-title":"The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins","volume":"453","author":"Pohla","year":"2008","journal-title":"Nature"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3205","article-title":"Interferon-\u03b3 regulates cellular metabolism and mRNA translation to potentiate macrophage activation","volume":"16","author":"Kamleh","year":"2015","journal-title":"Nat Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/gix087","article-title":"Differential roles of HIF-1\u03b1 and HIF-2\u03b1 in hypoxic gene regulation","volume":"23","author":"Hu","year":"2003","journal-title":"Mol Cell Biol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/nature19334","article-title":"Germinal centre hypoxia and regulation of antibody qualities by a hypoxia response system","volume":"537","author":"Zhang","year":"2016","journal-title":"Nature"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180853","article-title":"Inflammation dependent mTORC1 signaling interferes with the switch from keratinocyte proliferation to differentiation","volume":"12","author":"Warburg","year":"2017","journal-title":"PloS One"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02786","article-title":"Epidermal mTORC1 signaling contributes to the pathogenesis of psoriasis and could serve as a therapeutic target","volume":"9","author":"Buerger","year":"2018","journal-title":"Front Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.665647","article-title":"Recent updates on the involvement of PI3K\/AKT\/mTOR molecular cascade in the pathogenesis of hyperproliferative skin disorders","volume":"8","author":"Mercurio","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031693","article-title":"Predominant role of mTOR signaling in skin diseases with therapeutic potential","volume":"23","author":"Karagianni","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B81","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1038\/s41598-020-59996-z","article-title":"Hyperproliferation is the main driver of metabolomic changes in psoriasis lesional skin","volume":"10","author":"Heidenreich","year":"2020","journal-title":"Sci Rep"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1021\/pr500782g","article-title":"LC-MS metabolomics of psoriasis patients reveals disease severity-dependent increases in circulating amino acids that are ameliorated by anti-TNF\u03b1 treatment","volume":"14","author":"Man","year":"2015","journal-title":"J Proteome Res"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/gigascience\/gix087","article-title":"Lipidomics profiling reveals the role of glycerophospholipid metabolism in psoriasis","volume":"6","author":"Henno","year":"2017","journal-title":"GigaScience"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0003-0","article-title":"Differential glucose requirement in skin homeostasis and injury identifies a therapeutic target for psoriasis","volume":"24","author":"Canavese","year":"2018","journal-title":"Nat Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg effect: how does it benefit cancer cells","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem Sci"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-45139-7_81","article-title":"Integrative responses to IL-17 and TNF-\u03b1 in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis","volume":"131","author":"Lou","year":"2011","journal-title":"J Invest Dermatol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200535503","article-title":"IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis","volume":"36","author":"Zhang","year":"2006","journal-title":"Eur J Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2613.2009.00669.x","article-title":"Angiogenesis drives psoriasis pathogenesis","volume":"90","author":"Heidenreich","year":"2009","journal-title":"Int J Exp Pathol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2007.00112.x","article-title":"Overexpression of vascular endothelial growth factor (VEGF) receptors on keratinocytes in psoriasis: regulated by calcium independent of VEGF","volume":"12","author":"Man","year":"2008","journal-title":"J Cell Mol Med"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08889.x","article-title":"Altered expression of angiogenesis and lymphangiogenesis markers in the uninvolved skin of plaque-type psoriasis","volume":"160","author":"Imokawa","year":"2009","journal-title":"Br J Dermatol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2010.03.023","article-title":"Vascular endothelial growth factor (VEGF) in the pathogenesis of psoriasis\u2014a possible target for novel therapies","volume":"58","author":"Canavese","year":"2010","journal-title":"J Dermatol Sci"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.12.020","article-title":"PFKFB3, a direct target of p63, is required for proliferation and inhibits differentiation in epidermal keratinocytes","volume":"137","author":"Hamanaka","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111897","article-title":"Pyruvate kinase M2 mediates IL-17 signaling in keratinocytes driving psoriatic skin inflammation","volume":"41","author":"Janssens","year":"2022","journal-title":"Cell Rep"},{"key":"B95","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.immuni.2020.06.004","article-title":"Excessive polyamine generation in keratinocytes promotes self-RNA sensing by dendritic cells in psoriasis","volume":"53","author":"Berdyshev","year":"2020","journal-title":"Immunity"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Ishikawa","year":"2019","journal-title":"Nature"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.107451","article-title":"Lactate\/GPR81 signaling and proton motive force in cancer: role in angiogenesis, immune escape, nutrition, and Warburg phenomenon","volume":"206","author":"Brown","year":"2020","journal-title":"Pharmacol Ther"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.03.014","article-title":"Lactate reduces liver and pancreatic injury in Toll-like receptor- and inflammasome-mediated inflammation via GPR81-mediated suppression of innate immunity","volume":"146","author":"Hoque","year":"2014","journal-title":"Gastroenterology"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200304020-00004","article-title":"Ceramides and skin function","volume":"4","author":"Coderch","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.333","article-title":"Decrease of ceramides with very long-chain fatty acids and downregulation of elongases in a murine atopic dermatitis model","volume":"132","author":"Egawa","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.364","article-title":"Interferon-\u03b3 decreases ceramides with long-chain fatty acids: possible involvement in atopic dermatitis and psoriasis","volume":"134","author":"Tawada","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/ng1767","article-title":"Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis","volume":"38","author":"Palmer","year":"2006","journal-title":"Nat Genet"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra1011040","article-title":"Filaggrin mutations associated with skin and allergic diseases","volume":"365","author":"Irvine","year":"2011","journal-title":"N Engl J Med"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.04.031","article-title":"Cytokine modulation of atopic dermatitis filaggrin skin expression","volume":"120","author":"Howell","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.jaci.2011.12.989","article-title":"Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis","volume":"129","author":"Kezic","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.02.040","article-title":"Early-onset pediatric atopic dermatitis is characterized by TH2\/TH17\/TH22-centered inflammation and lipid alterations","volume":"141","author":"Brunner","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.08.015","article-title":"Role of sebaceous glands in inflammatory dermatoses","volume":"73","author":"Shi","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1334844","article-title":"Spatial transcriptomics reveals altered lipid metabolism and inflammation-related gene expression of sebaceous glands in psoriasis and atopic dermatitis","volume":"15","author":"Stockinger","year":"2024","journal-title":"Front Immunol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-nutr-071816-064916","article-title":"\u03b2-Hydroxybutyrate: a signaling metabolite","volume":"37","author":"Newman","year":"2017","journal-title":"Annu Rev Nutr"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3742","article-title":"Interleukin 17 is a chief orchestrator of immunity","volume":"18","author":"Veldhoen","year":"2017","journal-title":"Nat Immunol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.50","article-title":"The dichotomous nature of T helper 17 cells","volume":"17","author":"Stockinger","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.03.004","article-title":"The biological functions of T helper 17 cell effector cytokines in inflammation","volume":"28","author":"Ouyang","year":"2008","journal-title":"Immunity"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20110278","article-title":"HIF1\u03b1-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells","volume":"208","author":"Powell","year":"2011","journal-title":"J Exp Med"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.07.033","article-title":"Control of T(H)17\/T(reg) balance by hypoxia-inducible factor 1","volume":"146","author":"Berod","year":"2011","journal-title":"Cell"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.09.002","article-title":"The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism","volume":"33","author":"Powell","year":"2010","journal-title":"Immunity"},{"key":"B116","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.immuni.2020.09.015","article-title":"Second-strand synthesis-based massively parallel scRNA-Seq reveals cellular states and molecular features of human inflammatory skin pathologies","volume":"53","author":"Santori","year":"2020","journal-title":"Immunity"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1126\/science.aba6500","article-title":"Developmental cell programs are co-opted in inflammatory skin disease","volume":"371","author":"Hughes","year":"2021","journal-title":"Science"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.04.021","article-title":"Single-cell transcriptomics applied to emigrating cells from psoriasis elucidate pathogenic versus regulatory immune cell subsets","volume":"148","author":"Reynolds","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.04.021","article-title":"Obesity exacerbates imiquimod-induced psoriasis-like epidermal hyperplasia and IL-17\/IL-22 production in mice","volume":"24","author":"Kanemaru","year":"2015","journal-title":"Exp Dermatol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3704","article-title":"De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells","volume":"20","author":"Kanemaru","year":"2014","journal-title":"Nat Med"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1714","article-title":"Sterol metabolism controls TH17 differentiation by generating endogenous ROR\u03b3 agonists","volume":"11","author":"Nobs","year":"2015","journal-title":"Nat Chem Biol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2015.01.004","article-title":"Identification of natural ROR\u03b3 ligands that regulate the development of lymphoid cells","volume":"21","author":"Endo","year":"2015","journal-title":"Cell Metab"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20162069","article-title":"PPAR\u03b3 in dendritic cells and T cells drives pathogenic type-2 effector responses in lung inflammation","volume":"214","author":"Heikamp","year":"2017","journal-title":"J Exp Med"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.07.014","article-title":"Obesity drives Th17 cell differentiation by inducing the lipid metabolic kinase, ACC1","volume":"12","author":"Lee","year":"2015","journal-title":"Cell Rep"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2867","article-title":"The AGC kinase SGK1 regulates TH1 and TH2 differentiation downstream of the mTORC2 complex","volume":"15","author":"Esaki","year":"2014","journal-title":"Nat Immunol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.06.002","article-title":"Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways","volume":"32","author":"Pavel","year":"2010","journal-title":"Immunity"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.07.013","article-title":"Early-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin","volume":"138","author":"Noda","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1111\/all.14490","article-title":"Tape strips from early-onset pediatric atopic dermatitis highlight disease abnormalities in nonlesional skin","volume":"76","author":"Czarnowicki","year":"2021","journal-title":"Allergy"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.08.015","article-title":"The Asian atopic dermatitis phenotype combines features of AD and psoriasis with increased TH17 polarization","volume":"136","author":"Renert-Yuval","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.jaci.2015.05.049","article-title":"Early pediatric atopic dermatitis shows only a CLA+ TH2\/TH1 cell imbalance, whereas adults acquire CLA+ TH22\/TC22 cell subsets","volume":"136","author":"Thijs","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.jaci.2021.01.013","article-title":"Biomarkers in atopic dermatitis\u2014a review on behalf of the International Eczema Council","volume":"147","author":"Sugiyama","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.03.023","article-title":"Moving toward endotypes in atopic dermatitis: identification of patient clusters based on serum biomarker analysis","volume":"140","author":"Yang","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.1.164","article-title":"Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis","volume":"174","author":"Roesner","year":"2005","journal-title":"J Immunol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jdermsci.2015.11.007","article-title":"Impaired function of regulatory T cells in patients with psoriasis is mediated by phosphorylation of STAT3","volume":"81","author":"Beier","year":"2016","journal-title":"J Dermatol Sci"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1111\/all.12712","article-title":"Foxp3(+) regulatory T cells are expanded in severe atopic dermatitis patients","volume":"70","author":"Roesner","year":"2015","journal-title":"Allergy"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1096\/fj.14-268409","article-title":"Essential role of mitochondrial energy metabolism in Foxp3+ T-regulatory cell function and allograft survival","volume":"29","author":"Gualdoni","year":"2015","journal-title":"FASEB J"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89160","article-title":"Foxp3 drives oxidative phosphorylation and protection from lipotoxicity","volume":"2","author":"Apostolidis","year":"2017","journal-title":"JCI Insight"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201600522r","article-title":"The AMP analog AICAR modulates the Treg\/Th17 axis through enhancement of fatty acid oxidation","volume":"30","author":"Gualdoni","year":"2016","journal-title":"FASEB J"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3390","article-title":"Phosphatase PP2A is requisite for the function of regulatory T cells","volume":"17","author":"Van den Bossche","year":"2016","journal-title":"Nat Immunol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.10.001","article-title":"Distinct regulation of Th17 and Th1 cell differentiation by glutaminase-dependent metabolism","volume":"175","author":"Jha","year":"2018","journal-title":"Cell"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.09.031","article-title":"L-arginine modulates T cell metabolism and enhances survival and anti-tumor activity","volume":"167","author":"Diskin","year":"2016","journal-title":"Cell"},{"key":"B142","doi-asserted-by":"publisher","first-page":"6734","DOI":"10.1038\/ncomms7734","article-title":"Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome","volume":"6","author":"Geiger","year":"2015","journal-title":"Nat Commun"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3504","article-title":"CD69 controls the uptake of L-tryptophan through LAT1-CD98 and AhR-dependent secretion of IL-22 in psoriasis","volume":"17","author":"Tannahill","year":"2016","journal-title":"Nat Immunol"},{"key":"B144","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.cell.2016.08.064","article-title":"Metabolic reprograming in macrophage polarization","volume":"5","author":"Galv\u00e1n-Pe\u00f1a","year":"2014","journal-title":"Front Immunol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.it.2017.03.001","article-title":"Macrophage immunometabolism: where are we (going)","volume":"38","author":"Van den Bossche","year":"2017","journal-title":"Trends Immunol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.02.005","article-title":"Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization","volume":"42","author":"Lu","year":"2015","journal-title":"Immunity"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00270","article-title":"Metabolic modulation in macrophage effector function","volume":"9","author":"Diskin","year":"2018","journal-title":"Front Immunol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(03)00154-5","article-title":"Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1","volume":"496","author":"Cramer","year":"2013","journal-title":"Nature"},{"key":"B149","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.cell.2016.08.064","article-title":"Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages","volume":"167","author":"Kasraie","year":"2016","journal-title":"Cell"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.06.004","article-title":"Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation","volume":"24","author":"Su\u00e1rez-Fari\u00f1as","year":"2016","journal-title":"Cell Metab"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3523642","article-title":"Involvement of M1 macrophage polarization in endosomal Toll-like receptors activated psoriatic inflammation","volume":"2018","author":"Krawczyk","year":"2018","journal-title":"Mediators Inflammation"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1172\/jci27180","article-title":"Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation","volume":"116","author":"Everts","year":"2006","journal-title":"J Clin Invest"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(03)00154-5","article-title":"HIF-1alpha is essential for myeloid cell-mediated inflammation","volume":"112","author":"Glitzner","year":"2003","journal-title":"Cell"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2009.02255.x","article-title":"Interleukin (IL)-31 induces pro-inflammatory cytokines in human monocytes and macrophages following stimulation with staphylococcal exotoxins","volume":"65","author":"Kasraie","year":"2010","journal-title":"Allergy"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050500","article-title":"RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms","volume":"135","author":"Nestle","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-10-249540","article-title":"Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation","volume":"115","author":"Lande","year":"2010","journal-title":"Blood"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2833","article-title":"TLR-driven early glycolytic reprogramming via the kinases TBK1-IKK\u03f5 supports the anabolic demands of dendritic cell activation","volume":"15","author":"Bajwa","year":"2014","journal-title":"Nat Immunol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201404114","article-title":"Specific roles for dendritic cell subsets during initiation and progression of psoriasis","volume":"6","author":"Wollenberg","year":"2014","journal-title":"EMBO Mol Med"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1038\/nm1605","article-title":"Alpha1beta1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis","volume":"13","author":"Novak","year":"2007","journal-title":"Nat Med"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1159\/000131424","article-title":"Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production","volume":"202","author":"Salimi","year":"2005","journal-title":"J Exp Med"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1038\/nature06116","article-title":"Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide","volume":"449","author":"Kim","year":"2007","journal-title":"Nature"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501557","article-title":"Critical role of glycolysis in human plasmacytoid dendritic cell antiviral responses","volume":"196","author":"Bajwa","year":"2016","journal-title":"J Immunol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1007\/3-540-29856-8_28","article-title":"Immunomorphological and ultrastructural characterization of Langerhans cells and a novel inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema","volume":"106","author":"Wollenberg","year":"1996","journal-title":"J Invest Dermatol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-004-0069-2","article-title":"Immunoglobulin E-bearing antigen-presenting cells in atopic dermatitis","volume":"4","author":"Novak","year":"2004","journal-title":"Curr Allergy Asthma Rep"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20130351","article-title":"A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis","volume":"210","author":"Cervenka","year":"2013","journal-title":"J Exp Med"},{"key":"B166","doi-asserted-by":"publisher","first-page":"170ra16","DOI":"10.4049\/jimmunol.190.supp.114.21","article-title":"TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation","volume":"5","author":"Macia","year":"2013","journal-title":"Sci Transl Med"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20151448","article-title":"Critical role of fatty acid metabolism in ILC2-mediated barrier protection during malnutrition and helminth infection","volume":"213","author":"Furusawa","year":"2016","journal-title":"J Exp Med"},{"key":"B168","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.immuni.2020.04.021","article-title":"Lipid-droplet formation drives pathogenic group 2 innate lymphoid cells in airway inflammation","volume":"52","author":"Roager","year":"2020","journal-title":"Immunity"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.477","article-title":"Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis","volume":"134","author":"Newman","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf9794","article-title":"Kynurenines: tryptophan's metabolites in exercise, inflammation, and mental health","volume":"357","author":"Cervenka","year":"2017","journal-title":"Science"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02565","article-title":"Tryptophan metabolism in inflammaging: from biomarker to therapeutic target","volume":"10","author":"Sorgdrager","year":"2019","journal-title":"Front Immunol"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20215424","article-title":"Aryl hydrocarbon receptor in atopic dermatitis and psoriasis","volume":"20","author":"Furue","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032713-120245","article-title":"The aryl hydrocarbon receptor: multitasking in the immune system","volume":"32","author":"Stockinger","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1124\/pr.114.009001","article-title":"The aryl hydrocarbon receptor in barrier organ physiology, immunology, and toxicology","volume":"67","author":"Esser","year":"2015","journal-title":"Pharmacol Rev"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2011.02545.x","article-title":"Functional effects of interleukin 31 in human primary keratinocytes","volume":"66","author":"Kasraie","year":"2011","journal-title":"Allergy"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.10.085","article-title":"Tapinarof in the treatment of psoriasis: a review of the unique mechanism of action of a novel therapeutic aryl hydrocarbon receptor-modulating agent","volume":"84","author":"Bissonnette","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10775.x","article-title":"Efficacy and safety of topical WBI-1001 in patients with mild to moderate psoriasis","volume":"166","author":"Bissonnette","year":"2012","journal-title":"Br J Dermatol"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.05.004","article-title":"Tapinarof is a natural AhR agonist that resolves skin inflammation in mice and humans","volume":"137","author":"Smith","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2103629","article-title":"Phase 3 trials of tapinarof cream for plaque psoriasis","volume":"385","author":"Lebwohl","year":"2021","journal-title":"N Engl J Med"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2024.05.023","article-title":"Tapinarof cream 1% once daily: significant efficacy in moderate-to-severe atopic dermatitis (ADORING)","volume":"91","author":"Silverberg","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2001.04376.x","article-title":"Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in severe psoriasis: a randomized controlled trial","volume":"145","author":"Reitamo","year":"2001","journal-title":"Br J Dermatol"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07602.x","article-title":"Severe psoriasis treated with a new macrolide: everolimus","volume":"156","author":"Frigerio","year":"2007","journal-title":"Br J Dermatol"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12463","article-title":"Topical application of rapamycin ointment ameliorates atopic dermatitis-like skin lesions in NC\/Nga mice","volume":"23","author":"Yang","year":"2014","journal-title":"Exp Dermatol"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2014.09.018","article-title":"Metformin: from mechanisms of action to therapies","volume":"20","author":"Foretz","year":"2014","journal-title":"Cell Metab"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2013.256","article-title":"Metformin\u2014mode of action and clinical implications for diabetes and cancer","volume":"10","author":"Pernicova","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"B186","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jaad.2010.05.039","article-title":"Statin use and risk of first-time psoriasis diagnosis","volume":"65","author":"Brauchli","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1111\/febs.14739","article-title":"Insights into the role of endoplasmic reticulum stress in skin function and associated diseases","volume":"286","author":"Park","year":"2019","journal-title":"FEBS J"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.3109\/13880209.2015.1057652","article-title":"Metformin inhibits proliferation and proinflammatory cytokines of human keratinocytes in vitro via mTOR-signaling pathway","volume":"54","author":"Liu","year":"2016","journal-title":"Pharm Biol"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2012.05.001","article-title":"PPARs at the crossroads of lipid signaling and inflammation","volume":"23","author":"Wahli","year":"2012","journal-title":"Trends Endocrinol Metab"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2007.02.013","article-title":"PPARs and molecular mechanisms of transrepression","volume":"1771","author":"Ricote","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh423","article-title":"Treatment of active psoriatic arthritis with the PPARgamma ligand pioglitazone: an open-label pilot study","volume":"44","author":"Bongartz","year":"2005","journal-title":"Rheumatol (Oxford)"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2009.5","article-title":"Efficacy and safety of combination acitretin and pioglitazone therapy for psoriasis: a randomized, double-blind, placebo-controlled clinical trial","volume":"145","author":"Mittal","year":"2009","journal-title":"Arch Dermatol"},{"key":"B193","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1046\/j.0022-202x.2001.01626.x","article-title":"Topical peroxisome proliferator activated receptor-alpha activators reduce inflammation in irritant and allergic contact dermatitis models","volume":"118","author":"Sheu","year":"2002","journal-title":"J Invest Dermatol"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.4161\/derm.15025","article-title":"Peroxisome proliferator-activated receptors (PPARs) in dermatology: challenge and promise","volume":"3","author":"Sertznig","year":"2011","journal-title":"Dermatoendocrinol"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1172\/jci0215593","article-title":"SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver","volume":"109","author":"Horton","year":"2002","journal-title":"J Clin Invest"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2017.91","article-title":"SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology","volume":"13","author":"Shimano","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/535612","article-title":"Lipid disturbances in psoriasis: an update","volume":"2010","author":"Pietrzak","year":"2010","journal-title":"Mediators Inflammation"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2007.02260.x","article-title":"The lipid profile in psoriasis: a controlled study","volume":"21","author":"Akhyani","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp567","article-title":"Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database","volume":"31","author":"Mehta","year":"2010","journal-title":"Eur Heart J"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1201\/9781420039146.ch26","article-title":"Association between antidiabetic drugs and psoriasis risk in diabetic patients","volume":"72","author":"Wu","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.11.023","article-title":"Association between use of thiazolidinediones or other oral antidiabetics and psoriasis: a population based case-control study","volume":"58","author":"Brauchli","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1186\/s12895-016-0049-y","article-title":"Randomized placebo control study of insulin sensitizers in psoriasis patients with metabolic syndrome","volume":"16","author":"Singh","year":"2016","journal-title":"BMC Dermatol"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.4161\/derm.23874","article-title":"A marriage of two 'Methusalem' drugs for the treatment of psoriasis? Arguments for a pilot trial with metformin as add-on for methotrexate","volume":"5","author":"Glossmann","year":"2013","journal-title":"Dermatoendocrinol"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1592\/phco.31.11.1045","article-title":"Atorvastatin for the treatment of plaque-type psoriasis","volume":"31","author":"Faghihi","year":"2011","journal-title":"Pharmacotherapy"},{"key":"B205","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4314\/njm.v19i1.54216","article-title":"The remarkable beneficial effect of adding oral simvastatin to topical betamethasone for the treatment of psoriasis","volume":"19","author":"Naseri","year":"2010","journal-title":"Niger J Med"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.05.040","article-title":"Efficacy of simvastatin in plaque psoriasis: a pilot study","volume":"57","author":"Shirinsky","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.ijmr_717_16","article-title":"Dyslipidaemia & oxidative stress in patients of psoriasis","volume":"146","author":"Asha","year":"2017","journal-title":"Indian J Med Res"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvac017","article-title":"Photoinduced skin reactions of cardiovascular drugs-a systematic review","volume":"8","author":"G\u00f6tzinger","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"B209","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jaci.2009.06.049","article-title":"Murine atopic dermatitis responds to peroxisome proliferator-activated receptors \u03b1 and \u03b2\/\u03b4 (but not \u03b3) and liver X receptor activators","volume":"125","author":"Hatano","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.06.1171","article-title":"One-year safety and efficacy of tapinarof cream for plaque psoriasis: PSOARING 3","volume":"87","author":"Strober","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2015.07.011","article-title":"Gene regulation of filaggrin and other skin barrier proteins via aryl hydrocarbon receptor","volume":"80","author":"Furue","year":"2015","journal-title":"J Dermatol Sci"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1172\/jci65642","article-title":"Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis","volume":"123","author":"van den Bogaard","year":"2013","journal-title":"J Clin Invest"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.2147\/ccid.s177697","article-title":"Skin hydration is significantly increased by a cream formulated to mimic the skin's own natural moisturizing systems","volume":"11","author":"Spada","year":"2018","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13090","article-title":"The 24-hr, 28-day, and 7-day post-moisturizing efficacy of ceramides 1, 3, 6-II containing moisturizing cream in senile xerosis","volume":"32","author":"Lueangarun","year":"2019","journal-title":"Dermatol Ther"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.07.822","article-title":"Obesity, waist circumference, weight change, and risk of incident psoriasis: prospective data from the HUNT Study","volume":"137","author":"Snekvik","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181039","article-title":"An update on psoriasis and metabolic syndrome: a meta-analysis of observational studies","volume":"12","author":"Singh","year":"2017","journal-title":"PloS One"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08068.x","article-title":"Obesity in psoriasis: the metabolic, clinical and therapeutic implications","volume":"157","author":"Sterry","year":"2007","journal-title":"Br J Dermatol"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1007\/s13671-012-0034-6","article-title":"Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis","volume":"125","author":"Naldi","year":"2005","journal-title":"J Invest Dermatol"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1038\/nature21363","article-title":"Inflammation, metaflammation and immunometabolic disorders","volume":"542","author":"Hotamisligil","year":"2017","journal-title":"Nature"},{"key":"B220","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci92035","article-title":"Inflammatory mechanisms linking obesity and metabolic disease","volume":"127","author":"Saltiel","year":"2017","journal-title":"J Clin Invest"},{"key":"B221","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1172\/jci88876","article-title":"Role of innate and adaptive immunity in obesity-associated metabolic disease","volume":"127","author":"McLaughlin","year":"2017","journal-title":"J Clin Invest"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.06.053","article-title":"Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors","volume":"69","author":"Miller","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2019.04.020","article-title":"Comorbidities and the impact of atopic dermatitis","volume":"123","author":"Silverberg","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.11.031","article-title":"Association of atopic dermatitis with cardiovascular risk factors and diseases","volume":"137","author":"Standl","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B225","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.jaci.2016.01.015","article-title":"Risk of myocardial infarction, ischemic stroke, and cardiovascular death in patients with atopic dermatitis","volume":"138","author":"Andersen","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15727","article-title":"Atopic dermatitis and risk of hypertension, type 2 diabetes, myocardial infarction and stroke in a cross-sectional analysis from the Canadian Partnership for Tomorrow Project","volume":"177","author":"Drucker","year":"2017","journal-title":"Br J Dermatol"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1083432","article-title":"The role of short-chain fatty acids in inflammatory skin diseases","volume":"13","author":"He","year":"2023","journal-title":"Front Microbiol"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.1038\/nature12721","article-title":"Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells","volume":"504","author":"Xiao","year":"2013","journal-title":"Nature"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-018-1865-1","article-title":"Decreased expression of G-protein-coupled receptors GPR43 and GPR109a in psoriatic skin can be restored by topical application of sodium butyrate","volume":"310","author":"Krejner","year":"2018","journal-title":"Arch Dermatol Res"},{"key":"B230","doi-asserted-by":"publisher","first-page":"3294","DOI":"10.1038\/s41467-018-05470-4","article-title":"Microbial tryptophan catabolites in health and disease","volume":"9","author":"Roager","year":"2018","journal-title":"Nat Commun"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.01.042","article-title":"Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis","volume":"145","author":"Bangert","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B232","doi-asserted-by":"publisher","first-page":"7729","DOI":"10.1172\/JCI92035","article-title":"Spatial transcriptomics landscape of lesions from non-communicable inflammatory skin diseases","volume":"13","author":"Czarnowicki","year":"2022","journal-title":"Nat Commun"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2021.02.689","article-title":"Persistence of mature dendritic cells, T(H)2A, and Tc2 cells characterize clinically resolved atopic dermatitis under IL-4R\u03b1 blockade","volume":"6","author":"Mu","year":"2021","journal-title":"Sci Immunol"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.04.004","article-title":"Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march","volume":"139","author":"Czarnowicki","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B235","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s12016-014-8415-1","article-title":"Molecular biology of atopic dermatitis","volume":"47","author":"Mu","year":"2014","journal-title":"Clin Rev Allergy Immunol"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1172\/jci40202","article-title":"Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling","volume":"119","author":"Sarkar","year":"2009","journal-title":"J Clin Invest"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15382","article-title":"Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants","volume":"8","author":"Kong","year":"2017","journal-title":"Nat Commun"},{"key":"B238","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.02.972","article-title":"Endogenous glucocorticoid deficiency in psoriasis promotes inflammation and abnormal differentiation","volume":"137","author":"Geoghegan","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.1101\/gr.131029.111","article-title":"Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis","volume":"22","author":"Alekseyenko","year":"2012","journal-title":"Genome Res"},{"key":"B240","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2017.11.008","article-title":"Staphylococcus aureus and atopic dermatitis: a complex and evolving relationship","volume":"26","author":"Chang","year":"2018","journal-title":"Trends Microbiol"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.1186\/2049-2618-1-31","article-title":"Community differentiation of the cutaneous microbiota in psoriasis","volume":"1","author":"Reich","year":"2013","journal-title":"Microbiome"},{"key":"B242","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s40168-018-0533-1","article-title":"Alteration of the cutaneous microbiome in psoriasis and potential role in Th17 polarization","volume":"6","author":"Reich","year":"2018","journal-title":"Microbiome"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(21)00125-2","article-title":"Bimekizumab versus ustekinumab for moderate to severe plaque psoriasis (BE VIVID): a 52-week phase 3 trial","volume":"397","author":"Silverberg","year":"2021","journal-title":"Lancet"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa2102383","article-title":"Bimekizumab versus secukinumab in plaque psoriasis","volume":"385","author":"Reid","year":"2021","journal-title":"N Engl J Med"},{"key":"B245","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.08.013","article-title":"Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus","volume":"145","author":"Yang","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.1038\/ncb3629","article-title":"The impact of cellular metabolism on chromatin dynamics and epigenetics","volume":"19","author":"Reid","year":"2017","journal-title":"Nat Cell Biol"},{"key":"B247","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2015.10.014","article-title":"Ferroptosis: death by lipid peroxidation","volume":"26","author":"Yang","year":"2016","journal-title":"Trends Cell Biol"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Rusi\u00f1ol","year":"2012","journal-title":"Cell"},{"key":"B249","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3557","article-title":"Serine, glycine and one-carbon units: cancer metabolism in full circle","volume":"13","author":"Locasale","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1414582","article-title":"A review of psoriasis image analysis based on machine learning","volume":"11","author":"Li","year":"2024","journal-title":"Front Med (Lausanne)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1879634\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:39:39Z","timestamp":1784180379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1879634\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":250,"alternative-id":["10.3389\/fimmu.2026.1879634"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1879634","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"article-number":"1879634"}}